Effects of bevacizumab on plasma concentration of irinotecan and its metabolites in advanced colorectal cancer patients receiving FOLFIRI with bevacizumab as second-line chemotherapy

✍ Scribed by Yosuke Horita; Y. Yamada; Y. Hirashima; K. Kato; T. Nakajima; T. Hamaguchi; Y. Shimada

• Publisher: Springer
• Year: 2009
• Tongue: English
• Weight: 529 KB
• Volume: 65
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-009-1051-4